[Pyridoxal-5-phosphate in porphyria cutanea tarda].
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D003300:Copper / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007501:Iron / Q000097:blood / Q000652:urine; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008659:Metabolic Diseases / Q000150:complications; D008722:Methods; D008875:Middle Aged; D010847:Picolines / Q000627:therapeutic use*; D011164:Porphyrias / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology; D011166:Porphyrins / Q000378:metabolism / Q000652:urine; D011379:Prognosis; D011730:Pyridoxal / Q000494:pharmacology / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use*
D010847:Picolines; D011166:Porphyrins; D011730:Pyridoxal; D003300:Copper; D007501:Iron; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D011736:Pyridoxine
Pyridoxal-5-Phosphat bei Porphyria cutanea tarda.